Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2 versus 3 cycles of induction chemotherapy before concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma
ChiCTR1800018417Phase 3Completed
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin + radiotherapy in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Progression-free survival rate. Started Aug 2018; status: completed.
02
Drugs
cisplatin + radiotherapy
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR1800018417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018417.